Speeding up development of Ebola treatments and vaccines
21 October 2014 | By The European Medicines Agency
EMA encourages companies to apply for orphan designation...
List view / Grid view
News
Demos: Migrant health access fears put vulnerable people at risk
20 October 2014 | By Doctors of the World UK
A new report by the think-tank Demos, supported by Doctors of the World, argues that encouraging earlier detection of health conditions amongst migrant communities would reduce NHS spending on treatment and reduce the wider public health risk by catching transmittable diseases early...
Small businesses pitch for £2.5 million funding as SBRI Healthcare launches new competition
20 October 2014 | By SBRI Healthcare
Funding will accelerate development and NHS adoption of new technologies...
Masters Speciality Pharma – celebrating 30 years in business
20 October 2014 | By Masters Speciality Pharma
Masters Speciality Pharma celebrates the anniversary of its foundation by Dr Zulf Masters, OBE, 30 years ago...
European Commission approves IMBRUVICA in two forms of blood cancer
20 October 2014 | By Janssen
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor.
Abbott acknowledged by Science Magazine as a top employer
20 October 2014 | By Abbott
Abbott was named one of the Top 20 Employers by the journal Science...
Nasdaq welcomes Forward Pharma A/S (Nasdaq: FWP) to The Nasdaq Stock Market
20 October 2014 | By Nasdaq
Nasdaq announced that trading of Forward Pharma A/S (Nasdaq: FWP) commenced on The Nasdaq Stock Market on October 15, 2014....
AstraZeneca strengthens partnership with the University of Cambridge
20 October 2014 | By AstraZeneca
AstraZeneca, together with its global biologics research and development arm, MedImmune, announced that it has entered into four new collaborations with the University of Cambridge, building further on their existing partnership...
METTLER TOLEDO’s XS Balance line delivers performance and ergonomics to safeguard health in the workplace
16 October 2014 | By METTLER TOLEDO
The extended and improved XS balance line incorporates patented weighing technologies to ensure accurate results whilst ergonomic design features provide outstanding comfort to protect user health during daily weighing tasks.
METTLER TOLEDO launch new XPE Balance portfolio designed for performance and ease of compliance
16 October 2014 | By METTLER TOLEDO
The new line of XPE balances focuses on delivering accurate, compliant results and provides users with a high level of process security, suitable for even the strictest regulations...
Santen launches its own Subsidiary in Italy
16 October 2014 | By Santen Pharmaceutical Co
Santen Pharmaceutical Co., Ltd. announced its new wholly owned subsidiary in Italy...
Roche delivers solid sales growth for the first nine months of 2014
16 October 2014 | By Roche
Roche announce Q3 2014 results...
Public-private partnerships vital to advance Ebola treatment pipeline, says GlobalData Analyst
16 October 2014 | By GlobalData
In the battle against Ebola, incentives from governments and healthcare policymakers have been and will continue to be vital for advancing the current treatment pipeline, by mitigating the risk and up-front costs from pharmaceutical companies, says an analyst with research and consulting firm GlobalData...
FDA approves Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF) in the United States
16 October 2014 | By Roche
Roche announced that the U.S. Food and Drug Administration has approved Esbriet (pirfenidone) as a treatment for idiopathic pulmonary fibrosis in the United States...
Coulter Partners further strengthens its activities in Europe
15 October 2014 | By Coulter Partners
Coulter Partners, the Global Life sciences search specialist, is delighted to announce the appointment of Tobias (Toby) Ernberg as Executive Vice President...
